Project Grant R21MH138869
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$501K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
This Project Grant award of $475,388 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will fund research to characterize the transcriptional and neuro-immune consequences of loss of the high-confidence bipolar disorder risk gene KDM5B. The research aims to investigate the impact of stress on behavior and gene transcription in wild-type and KDM5B heterozygous mice, as well as characterize the neuro-immune responses in KDM5B+/-...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $714,615 to New York University School of Medicine to conduct research on dissecting the role of non-coding repeats in the genetics of psychiatric disorders like schizophrenia and bipolar disorder. The key objectives are to: Fine map regulatory features of a repeat expansion within the CACNA1C gene, which has been strongly associated with...
This Project Grant award of $185,165 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to understand how the microRNA miR-137 affects both metabolic and neuronal function. The research, conducted by Colorado State University, aims to further elucidate how miR-137 contributes to the neuropsychiatric symptoms and metabolic dysfunction observed in schizophrenia and bipolar disorder patients. Using the Drosophila...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $162,000 over 3 years to the Research Foundation For Mental Hygiene, Inc. (RFMH) to investigate the transcriptional diversity of the human mediodorsal thalamus and its role in psychiatric disorders, specifically schizophrenia and bipolar disorder. The key objectives of this research are to: 1) use single-nucleus RNA-sequencing to define...
The National Institute of Mental Health (NIMH) awarded a $206,875 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to investigate the impact of GRIN2B/GLUN2B disruption on dopaminergic function and related behaviors. The project aims to use a conditional Cre/Lox strategy in mice to assess the effects of diminished GLUN2B signaling on dopaminergic neuron firing, dopamine release, and downstream behaviors such as impulsivity and...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants provides $2,694,945 in funding to the Lieber Institute for Brain Development to conduct research on understanding the cellular and circuit function of human-induced pluripotent stem cell (hiPSC) models in relation to the complex and heterogeneous genetic risk factors and clinical/cognitive phenotypes of schizophrenia. The research aims to: 1) replicate and expand on...
This Project Grant award of $742,484 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program will fund research to characterize a genetic mouse model and delineate its function in the brain. The award to the University of Alabama at Birmingham will span 5 years from January 2025 to October 2029. The research aims to identify novel downstream targets in the mammalian brain, elucidate behavioral outcome measures, and generate new hypotheses...
This federal Project Grant award of $185,220, provided by the National Institute of Mental Health (NIMH) under CFDA Program 93.242 - Mental Health Research Grants, will support research to characterize the behavioral, neural, and inflammatory measures of response inhibition in patients with bipolar disorder. The key products and services to be delivered include: Characterizing response inhibition using self-report and performance-based measures in 100 patients with bipolar disorder and 50...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $443,671 to The Lieber Institute for Brain Development (LIBD) to investigate the molecular, cellular and circuit-level mechanisms underlying sustained attention deficits observed in neuropsychiatric disorders. The research leverages genetic and circuit-specific tools to dissect the role of the locus coeruleus-anterior cingulate cortex circuit and the...
This Project Grant award of $535,153 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a large-scale, single-cell characterization of molecular and cellular networks involved in mood regulation in major depressive disorder (MDD). The project aims to identify transcriptomic changes associated with MDD in a sample of 800 subjects across three key brain regions: the anterior cingulate cortex, basolateral amygdala, and...